My interpretation of the KEY AGM POINTS:2 Dec 2025 13:43
My Opinion Only – Not Financial Advice
AGM Point 1
What was said:
Brian said they hope to have assays in Q4, but stressed it’s not within the company’s control.
My interpretation:
Brian already sounds like he’s preparing the excuses: “it’s not within the company’s control.”
Then Omar quickly jumps in to reassure everyone that results will still be out this quarter — almost like he realised morale would tank and the share price could collapse if the Q4 promise was broken again(remember last year).
So the question remains: Will they or won’t they deliver assays this quarter?
AGM Point 2
What was said:
When asked why assays weren’t fast-tracked, Brian said that they believed the cost-benefit didn’t justify it, and that expediting wouldn’t add shareholder value.
My interpretation:
If management genuinely believe they’re sitting on a 5x Havieron-scale discovery and huge future valuation — then how on earth does spending ~£5k on fast-tracking assays not create shareholder value?
Unless of course… the initial spot assays don’t show anything exciting, in which case fast-tracking becomes pointless. (More on that later.)
AGM Point 3
What was said:
Brian said that based on what he and Callum saw on site, they have “confidence” in Juno.
My interpretation:
If they’re that confident, then why didn’t they fast-track?
£5k is probably less than the cost of the unnecessary helicopter ride Brian took to Juno at the start of drilling. If confidence is high, accelerating the results would only help — unless there’s nothing to accelerate.
AGM Point 4
What was said:
Omar compared Juno to Havieron, saying it wasn’t until the second set of drill results that the market understood the scale.
My interpretation:
Aha! This sounds like a subtle message: JUD001 and JUD002 may be what has been hyped so wait for JUD003, JUD004 to JUD100.
And that circles back to why they didn’t fast-track the assays: if the first holes are underwhelming, fast-tracking does nothing for “shareholder value.”
Sign In
Follow the stocks
